Cited by 72Schizophrenia research and treatmentSubstance Abuse Treatment and OutcomesHomelessness and Social Issues

Medical comorbidity in patients with schizophrenia and alcohol dependence

Open access
Batki, Steven L., Meszaros, Zsuzsa S., Strutynski, Katherine, Dimmock, Jacqueline A., Leontieva, Luba, Ploutz-Snyder, Robert, Canfield, Kelly, Drayer, Rebecca A.·2009·Schizophrenia Research

Abstract

Background Schizophrenia and alcohol dependence are major risk factors for a variety of medical problems, yet there has been little research on the medical status of patients in whom both conditions coexist.Methods We assessed the prevalence and severity of medical illness in 80 patients with schizophrenia or schizoaffective disorder and comorbid alcohol use disorders who entered a controlled trial of monitored naltrexone treatment, and analyzed the relationship between medical illness burden and demographic variables, alcohol and other substance use, and psychosis. Participants underwent physical examination, laboratory tests, medical record review and standardized assessments of medical illness burden, alcohol and other substance use, and psychosis. Nested block multiple regression analyses were used to assess the contribution to illness burden made by demographic variables, alcohol and substance use, and psychosis severity.Results 83% of participants had at least one chronic medical illness, hypertension being the most common (43%). Medical comorbidity in this cohort was more severe than for schizophrenia patients in the CATIE trial (Chwastiak, L., Rosenheck, R., McEvoy, J.P., Keefe, R.S., Swartz, M.S., Lieberman, J.A., 2006. Interrelationships of Psychiatric Symptom Severity, Medical Comorbidity, and Functioning in Schizophrenia. Psychiatr. Serv., 57(8), 1102-1109.); the prevalence of hypertension, chronic obstructive pulmonary disease, and coronary artery disease, was more than twice greater. Medical illness burden correlated with alcohol use severity, but appeared to be independent of other substance use or psychosis severity.Conclusions Patients with co-occurring alcohol use disorder may have significantly more medical illness burden than patients with schizophrenia or schizoaffective disorder alone. Interventions to reduce alcohol use may be necessary to lessen medical morbidity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.schres.2008.10.016

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Batki, S. L., Meszaros, Z. S., Strutynski, K., Dimmock, J. A., Leontieva, L., Ploutz-Snyder, R., Canfield, K., & Drayer, R. A.
Affiliations
  • San Francisco VA Medical Center (US)
  • SUNY Upstate Medical University (US)
  • National Aeronautics and Space Administration (US)
  • University of Rochester Medicine (US)
Corresponding author
Batki, Steven L.
Venue
Schizophrenia Research
Publisher
Elsevier BV
Published
2009-02
Volume
107
Issue
2-3
Pages
139-146
ISSN
0920-9964 (ISSN-L)
OpenAlex
W2073909219
Cited by
72
References
31
Citations by year
2026: 2 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 6 · 2014: 4 · 2013: 3 · 2012: 7
FWCI
3.98
Type
journal article
Language
en
Open access
Locations
  • Schizophrenia Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5r01aa013655-04)
  • National Institute on Alcohol Abuse and Alcoholism (R01-AA-013655)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Health Professions › General Health Professions › Homelessness and Social Issues
Keywords
schizophrenia, alcoholism
MeSH terms
Adult, Alcoholism, Chronic Disease, Cross-Sectional Studies, Female, Health Status, Health Surveys, Humans, Hypertension, Male, Middle Aged, New York, Psychotic Disorders, Schizophrenia, Cohort Studies, Comorbidity, Substance-Related Disorders, Alcohol-Related Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review